Brief: Janone Readies Clinical Supply Of Lead Product Candidate Jan101 For Distribution To Phase 2B Trial Sites
June 23 (Reuters) - Janone Inc JAN.O :
* JANONE READIES CLINICAL SUPPLY OF LEAD PRODUCT CANDIDATE
JAN101
FOR DISTRIBUTION TO PHASE 2B TRIAL SITES
* JANONE INC - FULLY PREPARED TO COMMENCE PHASE 2B TRIALS OF
JAN101 FOR PERIPHERAL ARTERY DISEASE (PAD) AS SOON AS NEW
PROTOCOL IS APPROVED BY FDA
Source text for Eikon: ID:nPncch431a
Further company coverage: JAN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AI Financial
See all newsCorrected: UPDATE 1-Trump-linked fintech firm AI Financial sells unit to PrimeDelta
Trump-linked fintech AI Financial sells unit to Prime Delta
Perpetuals.com ends acquisition talks with Trump-linked crypto firm
Brief: ALT5 Sigma Corporation Restores Compliance With Nasdaq Periodic Filing Requirements
Brief: Alt5 Sigma Expects To File Its Quarterly Report On Form 10-Q